Stockreport

Summit Therapeutics (SMMT) Is Up 6.9% After Phase III Ivonescimab Data And FDA Filing - What's Changed [Yahoo! Finance]

Summit Therapeutics Inc.  (SMMT) 
Last summit therapeutics inc. earnings: 6/12 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: summitplc.com/investors/investor-centre
PDF in Copenhagen, showing improved intracranial progression-free survival in EGFR-mutated non-small cell lung cancer and confirming that a Biologics License Application has [Read more]